[1] Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X)[J]. Diabetes, 1992, 41(6):715-722. [2] Klein BE, Klein R, Lee KE. Components of metabolic syndrome and the risk of cardiovascular diseases and diabetes in beaver dam[J]. Diabetes Care, 2002, 25(8): 1790-1794. [3] Kaplan NM. The deadly quarter:upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension[J]. Arch InternMed, 1989, 149(5):1514-1520. [4] Van Wetering S, van den Berk N, van Buul JD, et al. VCAM-1-mediated Rac signaling controls endothelial cellcellcontacts and leukocyte transmigration[J]. Am J Physiol Cell Physiol, 2003, 285(8):343-352. [5] Matsumura Y, Kito S, Tanida Y, et al. Antihypertensive effect of sesamin III Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats[J]. Bid Pharm Bull, 1998, 21(5):469-473. [6] 孔祥, 杨解人. 芝麻素对肾性高血压大鼠主动脉收缩功能、NO 和ET 含量的影响[J]. 中国实验方剂学杂志, 2006, 12(4):47-49. [7] Barnard RJ, Roberts CK, Varon SM, et al. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome[J]. J Appl Physiol, 1998, 84(4):1311-1315. [8] Schmidt AM, Yan SD, Wautier JL, et al. Chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis activation of receptor for advanced gly cation and products: a mechanism for ann marie schmidt[J]. Circ Res, 1999, 84(8):489-497. [9] Ceriello A, Quagliaro L, Piconi L, et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment[J]. Diabetes, 2004, 53(3):701-710. [10] Tsuruoka N, Kidokoro A, Matsumoto I, et al. Modulating effect of sesamin, a functional ligan in sesame seeds, on the transcription levels of lipid-and alcohol-metabolizing enzymes in rat liver:a DNA microarray study[J]. Biosci Biotechnol Biochem, 2005, 69(1):179-188. [11] Altannavch TS, Roubalova K. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation[J]. Physiol Res, 2004, 53(4):77-82. [12] Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species[J]. Blood, 2004, 104(8):2385-2393. [13] Keshavan P, Deem TL, Schwemberger SJ, et al. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration1[J]. J Immunol, 2005, 174(6): 3710-3718. |